Bentong Yu

机构：Nanchang University, Jiangxi Provincial Cancer Hospital, First Affiliated Hospital of Nanchang University · ORCID：0000-0001-6396-1931

发表论文 91 篇 · 总被引 2523 次 · h-index 28

代表论文

• Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial (2024 · The Lancet Respiratory Medicine · 被引 122)
• Neoadjuvant Osimertinib for Resectable EGFR -Mutated Non–Small Cell Lung Cancer (2025 · Journal of Clinical Oncology · 被引 78)
• PET/CT based cross-modal deep learning signature to predict occult nodal metastasis in lung cancer (2023 · Nature Communications · 被引 67)
• Integrated multiomics signatures to optimize the accurate diagnosis of lung cancer (2025 · Nature Communications · 被引 39)
• Aggregation‐Induced Emission Photosensitizer‐Engineered Anticancer Nanomedicine for Synergistic Chemo/Chemodynamic/Photodynamic Therapy (2023 · Advanced Healthcare Materials · 被引 31)
• Superoxide dismutase mimetic nanozymes attenuate cardiac microvascular ischemia–reperfusion injury associated with hyperhomocysteinemia (2024 · Chemical Engineering Journal · 被引 20)